Adaptive Biotechnologies Corp ($ADPT)
Filing Information
| Accession Number | 0001780664-26-000018 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 31, 2026 |
| Document | View SEC Filing |
Transactions
10
Total Shares
145,512
Total Value
$1,072,389.80
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President and COO | Common Stock | โ | Mar 27, 2026 | Exercise/Conversion | 14,722 | $7.27 | $107,028.94 | 483,614 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Mar 27, 2026 | Sale | 2,738 | $12.49 | $34,197.62 | 480,876 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Mar 27, 2026 | Sale | 16,322 | $13.48 | $220,020.56 | 464,554 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Mar 30, 2026 | Exercise/Conversion | 14,722 | $7.27 | $107,028.94 | 479,276 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Mar 30, 2026 | Sale | 19,060 | $12.63 | $240,727.80 | 460,216 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Mar 31, 2026 | Exercise/Conversion | 14,722 | $7.27 | $107,028.94 | 474,938 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Mar 31, 2026 | Sale | 19,060 | $13.45 | $256,357.00 | 455,878 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Mar 27, 2026 | Exercise/Conversion | 14,722 | $0.00 | $0.00 | 140,607 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Mar 30, 2026 | Exercise/Conversion | 14,722 | $0.00 | $0.00 | 125,885 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Mar 31, 2026 | Exercise/Conversion | 14,722 | $0.00 | $0.00 | 111,163 | Direct | โ | View Details |